2014
DOI: 10.1007/s11745-014-3893-8
|View full text |Cite
|
Sign up to set email alerts
|

Nitrooleate Mediates Nitric Oxide Synthase Activation in Endothelial Cells

Abstract: Nitrated lipids such as nitrooleate (OLA-NO2) can act as endogenous peroxisome proliferator-activated receptor gamma (PPARγ) ligands to exert vascular protective effects. However, the molecular mechanisms regarding nitric oxide (NO) production and its regulation are not fully defined in the vasculature. Here, we show that OLA-NO2 increased endothelial NO release by modulating activation of endothelial nitric oxide synthase (eNOS) in endothelial cells. Treatment with OLA-NO2 (3 μM) increased NO release in a tim… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…The replacement of HSP90 with its associated proteins can be critical to the regulation of those proteins, as demonstrated in studies that showing that nitrated lipid, OLA-NO 2 , enhances eNOS/Hsp90 interaction by replacing the eNOS/cav1 interaction, resulting in increasing eNOS activity [ 42 ]. We sought to determine whether an Aβ-induced augmentation of eNOS/HSP90 had an effect on Akt/HSP90.…”
Section: Resultsmentioning
confidence: 99%
“…The replacement of HSP90 with its associated proteins can be critical to the regulation of those proteins, as demonstrated in studies that showing that nitrated lipid, OLA-NO 2 , enhances eNOS/Hsp90 interaction by replacing the eNOS/cav1 interaction, resulting in increasing eNOS activity [ 42 ]. We sought to determine whether an Aβ-induced augmentation of eNOS/HSP90 had an effect on Akt/HSP90.…”
Section: Resultsmentioning
confidence: 99%
“…This latter mechanism can serve as an adaptive response to oxidative stress, since the physiological concentrations (~1 μM) that are generated clinically [20-22] are sufficient to mediate pleiotropic signaling responses that promote the resolution of inflammation [23]. Recent evidence suggests that these pluripotent signaling mediators can, as a consequence of post-translational protein modification, regulate many physiological and pathological processes by affecting a whole range of mammalian cell functions (e.g.…”
Section: Introductionmentioning
confidence: 99%
“…Recent evidence suggests that these pluripotent signaling mediators can, as a consequence of post-translational protein modification, regulate many physiological and pathological processes by affecting a whole range of mammalian cell functions (e.g. the activation of macrophages and neutrophils, vasorelaxation, angiogenesis and platelet aggregation) [2, 3, 22, 24]. …”
Section: Introductionmentioning
confidence: 99%
“…In line with the activation by Src was the increased phosphorylation of eNOS at the stimulating site Ser1177 in response to oxidative stress [ 31 ] implicated in anthrax pathology [ 32 ]. However, the inhibiting site Ser113 [ 33 ] also displayed an increased phosphorylation thus precluding a conclusion on the functional status of this enzyme.…”
Section: Resultsmentioning
confidence: 99%